XML 15 R30.htm IDEA: XBRL DOCUMENT v3.20.1
License and Agreements (Details) - USD ($)
1 Months Ended 3 Months Ended 11 Months Ended 12 Months Ended
Jun. 30, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 24, 2019
Aug. 31, 2019
Jun. 30, 2019
Apr. 30, 2019
Jan. 31, 2019
May 31, 2018
Mar. 31, 2018
License and Agreements (Textual)                        
Assignment fee                       $ 100,000
Milestone fee   $ 50,000   $ 50,000                
Common shares outstanding price percentage   1.00%   1.00%                
Amount of Common shares due payable       220,666                
Fair value of common stock       1,132,000                
Closing stock price           $ 5.13            
Description of license and agreements       As of December 31, 2019, the Company has not paid the $50,000 or issued the shares and has included the $50,000 in accounts payable and the share amount due as a research and development expense payable. The Company paid the $50,000 and issued the shares in January 2020.                
Research and development cost     $ 848,809 $ 8,822,226                
Research and development [Member]                        
License and Agreements (Textual)                        
Research and development cost       81,000 $ 192,000              
Patheon Development Services [Member]                        
License and Agreements (Textual)                        
Assignment fee $ 273,000                      
Agreement term, description The Company entered into a one-year agreement with Patheon Development Services, Inc. to provide initial contract manufacturing services for the Company’s drug product candidates.                      
Master Services [Member]                        
License and Agreements (Textual)                        
Assignment fee                   $ 4,412,000 $ 1,790,000  
Research and development cost       2,746,000 $ 273,000              
Irisys, LLC [Member]                        
License and Agreements (Textual)                        
Assignment fee                 $ 1,352,000      
Research and development cost       887,000                
CoreRx [Member]                        
License and Agreements (Textual)                        
Assignment fee               $ 918,794        
Research and development cost       $ 290,000                
Conform Clinical Development, Inc. [Member]                        
License and Agreements (Textual)                        
Assignment fee             $ 1,258,400          
Research and development cost   $ 977,000